Tulips to increase production to 5 million COVID-19 swabs per week

As of now, It is producing 2 million COVID-19 swabs per week

Tulips, Swabs, Suparshva Swabs, COVID-19, Covid-19 testing, COVID-19 swab production, ICMR, National Institute of Virology

Amid calls for increased coronavirus testing nationwide, Suparshva Swabs (TULIPS), India’s leading personal hygiene consumer product innovator and owner of the fast-growing popular brand Tulips has announced that it is currently producing over 2 million COVID-19 SWABS per week, which would increase to over 5 million per week by the end of May 2020, to accelerate COVID-19 testing.

To meet the national need for COVID-19 tests, the company is ramping up production, by converting its production lines and reconfiguring equipment, of some of its manufacturing capabilities. The company has the largest installed capacity of Cotton buds in Asia & possesses capability of taking the COVID-19 swab production to over 30 million swabs per week, if required in due course.

The intent is to make the country self-reliant in nasal and throat swabs, a critical component in fighting COVID-19 war and rely less on supplies from other countries, in these testing times. With rising number of COVID-19 cases, the company shifted focus to affordable swabs, as domestically produced swabs would cost one-tenth the imported throat swabs.

TULIPS novel polyester spun swabs innovation has excellent collection and release properties. Polyester fiber has been tested and validated for use in specimen collection in microbiology, RT-PCR analysis.

TULIPS is the first to develop & receive the ICMR (Indian Council of Medical Research) and NIV (National Institute of Virology) validation for domestically produced ‘polyester’ swabs. This is significant as COVID Test swabs were not manufactured in India, and were imported from the US or China. With global demand increasing, it became difficult and expensive to get swabs from other nations.

Today the country needs the swabs in large numbers to fight the COVID-19 war. As per WHO, reconfiguring health systems is vital to tackling COVID-19. This is significant amid calls for more testing for coronavirus and warnings from the medical experts that reopening the nation’s economy without increasing the capacity to test for the virus poses serious risks.

"We are convinced that widespread testing of those currently infected with COVID-19 will bring us out of the current lockdown as we do our bit to help the country return to normalcy. We are working at full speed as time is of the essence, and a lot is at stake. Our dedicated employees are working 24 x 7, to ensure free availability.  We developed Polyester swabs for COVID testing by converting the 100% cotton processing lines, to produce polyester swabs, within 10 days flat,” said Rahul Jain, Partner, Suparshava Swabs.

What is unique ss that the entire development was done in-house and the trials were done on main production lines, which enabled it to start producing the same day it received the ICMR approval.

“To fight COVID-19, India will have to increase testing and may need over 7 – 10 million swabs every week, to enable the nation to safely begin easing lockdown restrictions and open the economy. This is significant as India plans aggressively to test its billion plus population for COVID-19 to ensure the virus doesn't spread faster when some of the regulations are relaxed,” said Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), New Delhi ”